Home » Newsletters » BioWorld Science

BioWorld Science

May 21, 2003

View Archived Issues

Bayer claims new PPARdelta activators in recent patent

New IKK-2 inhibitors for cancer and inflammation reported by Pharmacia (Pfizer)

Novel CCR1 antagonists in early development at Pfizer

Pfizer presents new opioid antagonists for IBS, drug abuse, depression, etc.

Lilly researchers describe new antitumor agents with utility in colorectal cancer

New HCV NS3 protease inhibitors in Vertex research pipeline

Long-acting, locally effective antimuscarinic agents developed at Pharmacia (Pfizer)

HIV integrase inhibitors designed by Italian team

Ferring reveals novel DPP-IV inhibitors in recent patents

Arginine supplementation to be studied for sickle cell disease

Symlin dose-titration study results reported

Alferon N demonstrates positive outcome in animal model of SARS

Interim results from phase IV Keppra SKATE study

Isis and Ercole collaborate on antisense drugs that regulate alternative RNA splicing

CAT presents six-month interim update

Bexarotene reported effective in parapsoriasis

Clevudine safe and effective in chronic HBV infection

Antifungal activity of SPK-843 against clinical isolates

Promising results obtained for Bay-38-4766 in guinea pig CMV model

Anti-HBV dinucleotide with different mechanism of action from adefovir dipivoxil

European introduction of contraceptive transdermal matrix patch begins

Texas Biotechnology renamed

Iclaprim reported effective against several drug-resistant bacterial strains

EPI-2010 development discontinued

AtheroGenics reveals new asthma therapy at ATS 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...